Our findings indicate that SMAD2 signaling and SMAD1 signaling as well as ERK signaling are responsible for defective early bone development in CFC syndrome, providing a novel insight on the pathological mechanism and therapeutic targets. The gene discussed is SMAD1; the disease is cardiofaciocutaneous syndrome.